IRF7 and melanoma: In this study, we found that a small amount of IRF7 in resting tumor cells can be modified by NOS1-mediated S-nitrosylation, thereby inhibiting IRF7-mediated transcription of IFNB1, resulting in impaired activation of the type I IFN signaling in melanoma cells.